Title : Is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Teaching new tricks to old dogs.

Pub. Date : 2009 Oct

PMID : 19560877






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Is it the time for metformin to take place in adjuvant treatment of Her-2 positive breast cancer? Metformin erb-b2 receptor tyrosine kinase 2 Homo sapiens
2 Metformin causes Her-2 suppression via the inhibition of mTOR in breast cancer cells. Metformin erb-b2 receptor tyrosine kinase 2 Homo sapiens
3 Thus, we believe that the time has arrived both to target insulin reduction and to alter Her-2 oncogene based molecular pathogenetic steps in breast cancer by using metformin as an adjuvant therapy in breast cancer patients. Metformin erb-b2 receptor tyrosine kinase 2 Homo sapiens